Similarly, the observed incidence for dyslipidaemia in 2020 was higher, although marginally significant, than the predicted incidence; the difference in observed and predicted incidence rates (95% CI) was 0.72 (−0.02 to 1.46).
← all excerpts
Impact of the COVID-19 pandemic on the incidence of cardiometabolic risk factors among workers: results from the Japan Epidemiology Collaboration on Occupational Health study.
1
—
—